Drug therapies tailored to the DNA profiles of individual patients could change the face of medicine, but such treatments aren't commonly used in the clinic
The Scientist
Most Recent
The source of the deadly bacterial infections remains unkown
As Germany grapples with an E. coli outbreak, a new strain of MRSA appears in Europe
A snapshot of the most highly ranked articles in vaccination and related areas, from Faculty of 1000
As epidemics swept across the United States in the 19th century, the US government recognized the pressing need for a national lab dedicated to the study of infectious disease. In 1887, the government set its sights on a small lab located in the Mari
A highly virulent strain of E. coli has caused an unusually high number of severe kidney disease
Building tiny houses to study how bacteria behave in natural environments
Clostridium difficile is evolving more robust toxicity, repeatedly attacking its victims, and driving the search for alternative therapies to fight the infection.
A Duke University researcher survives a sticky situation at a federal research institution to make major strides in determining the genetic roots of Staphylococcus aureus antibiotic resistance.
Follow The Scientist
Advertisement
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
